Roche Third-Quarter Sales Beat Consensus, Partly on Japan One-Off
J.P. Morgan analysts say the outperformance was partly driven by a one-off gain in Japan related to the timing of a new software system implementation.
Roche Holding's reported third-quarter sales ahead of consensus expectations, but the outperformance was partly driven by a one-off gain in Japan, J.P. Morgan analysts say in a research note. The Swiss drugmaker's sales were boosted by the timing of the implementation of a new software system in Ja…